Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-02-22 @ 9:38 AM
Study NCT ID:
NCT01891968
Status:
COMPLETED
Last Update Posted:
2018-04-23
First Post:
2013-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation
Sponsor:
Organization: